ADC Therapeutics SA (ADCT)
1.285
-0.02
(-1.15%)
USD |
NYSE |
Sep 09, 14:56
ADC Therapeutics Total Liabilities (Quarterly) : 507.58M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 507.58M |
| March 31, 2026 | 507.87M |
| December 31, 2025 | 509.77M |
| September 30, 2025 | 527.94M |
| June 30, 2025 | 520.74M |
| March 31, 2025 | 510.76M |
| December 31, 2024 | 524.62M |
| September 30, 2024 | 521.02M |
| June 30, 2024 | 503.45M |
| March 31, 2024 | 502.42M |
| December 31, 2023 | 503.03M |
| September 30, 2023 | 521.08M |
| June 30, 2023 | 515.89M |
| Date | Value |
|---|---|
| March 31, 2023 | 429.99M |
| December 31, 2022 | 411.41M |
| September 30, 2022 | 426.98M |
| June 30, 2022 | 405.12M |
| March 31, 2022 | 419.22M |
| December 31, 2021 | 451.88M |
| September 30, 2021 | 450.67M |
| June 30, 2021 | 220.47M |
| March 31, 2021 | 163.74M |
| December 31, 2020 | 178.19M |
| September 30, 2020 | 145.47M |
| June 30, 2020 | 177.54M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Basilea Pharmaceutica AG | -- |
| Santhera Pharmaceuticals Holding AG | -- |
| BeOne Medicines Ltd. | 3.973B |
| AC Immune SA | 142.85M |
| CRISPR Therapeutics AG | 904.22M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 279.38M |
| Shareholders Equity (Quarterly) | -228.20M |
| Debt to Equity Ratio | -0.5152 |
| Current Ratio | 3.031 |
| Net Debt Paydown Yield | 49.76% |